MORE DETAILS AS TO EXACTLY WHAT LED UP TO THAT CRASH. MEANWHILE, PARISH LEADERS FACING SOME MAJOR CHARGES ACCUSED OF SHARING PROTECTED INFORMATION WITH AN ARRESTED DEFENDANT ABOUT HIS CRIMINAL CASE.

Eli Lilly opposes the White House's push to codify 'most favored nation' drug pricing, Lilly CEO Dave Ricks said in an interview with CNBC. Lilly is one of more than a dozen pharmaceutical companies ...

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. By Rebecca Robbins Eli Lilly reached a deal on Tuesday to buy Centessa ...

Eli Lilly has published a video about how medicines affect lives to mark its 150th anniversary and the arrival of college basketball stars in its home city. Indianapolis-based Lilly will celebrate 150 ...

Lafayette police arrested two adults and a juvenile Tuesday morning after an armed robbery at a business along the Southeast Evangeline Thruway. Officers responded around 6:24 a.m. to a report of a ...

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...

Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year. Lilly’s once-daily pill, called Foundayo, was approved ...

Eli Lilly & Co.’s Zepbound is helping to solve one of the most intractable health challenges of our time: obesity. Now, the drugmaker is taking on another significant public health predicament: sleep ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Food and Drug Administration has approved Foundayo, Eli Lilly’s new GLP-1 pill to treat ...

March 29 (Reuters) - Insilico Medicine said on Sunday it is partnering with Eli Lilly (LLY.N), opens new tab in a deal worth up to $2.75 ‌billion, expanding an existing collaboration on AI-powered ...

Eli Lilly (LLY) and Centessa Pharmaceuticals (CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, ...

Alex Zhavoronkov, CEO of Insilico Medicine, can’t stop complimenting Eli Lilly. “Lilly is better in AI than Insilico, and no other company is better in AI than us … except for these guys,” he said. He ...